Cargando…
Lung resistance-related protein (LRP) predicts favorable therapeutic outcome in Acute Myeloid Leukemia
There is conflicting evidence that MDR1, MRP2 and LRP expression is responsible for chemotherapy resistance. We conducted this study to explore their role in AML therapy outcomes. Bone marrow and peripheral blood samples of 90 AML patients, receiving chemotherapy, were analyzed by real time PCR. Gen...
Autores principales: | Kulsoom, Bibi, Shamsi, Tahir Sultan, Afsar, Nasir Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344578/ https://www.ncbi.nlm.nih.gov/pubmed/30674943 http://dx.doi.org/10.1038/s41598-018-36780-8 |
Ejemplares similares
-
Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
por: Kulsoom, Bibi, et al.
Publicado: (2018) -
Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin
por: Kulsoom, Bibi, et al.
Publicado: (2018) -
Stress, anxiety, and depression among medical students in a multiethnic setting
por: Kulsoom, Bibi, et al.
Publicado: (2015) -
Outcomes of 1st Remission Induction Chemotherapy in Acute Myeloid Leukemia Cytogenetic Risk Groups
por: Zehra, Samreen, et al.
Publicado: (2016) -
Successful management of colistin- and carbapenem-resistant Klebsiella pneumoniae-associated ecthyma gangrenosum in acute myeloid leukemia: A rare complication
por: Jamal, Aisha, et al.
Publicado: (2022)